Altamira Therapeutics Ltd. Noncurrent Liabilities
Altamira Therapeutics Ltd. (CYTOF) had Noncurrent Liabilities of $746.88 thousand as of 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Notes
ifrs-full:NoncurrentLiabilities · last filed 2025-08-29
- 2023-12-31: Noncurrent Liabilities 346.63K CHF.
- 2023-06-30: Noncurrent Liabilities 2.66M CHF.
- 2022-12-31: Noncurrent Liabilities 1.74M CHF.
- 2022-06-30: Noncurrent Liabilities 1.95M CHF; Noncurrent Liabilities as first filed 1.01M CHF.
CHF
| Period end | Noncurrent Liabilities | Noncurrent Liabilities as first filed |
|---|---|---|
| 2023-12-31 | 346.63K CHF 20-F/A · filed 2024-04-22 | |
| 2023-06-30 | 2.66M CHF 6-K · filed 2023-09-12 | |
| 2022-12-31 | 1.74M CHF 20-F/A · filed 2024-04-22 | |
| 2022-06-30 | 1.95M CHF 6-K/A · filed 2023-08-21 | 1.01M CHF 6-K · filed 2022-11-30 |
| 2021-12-31 | 1.27M CHF 6-K/A · filed 2023-08-21 | |
| 2021-06-30 | 578.81K CHF 6-K · filed 2021-09-08 | |
| 2020-12-31 | 999.56K CHF 20-F · filed 2022-04-12 | |
| 2020-06-30 | 1.06M CHF 6-K/A · filed 2020-09-17 | |
| 2019-12-31 | 911.95K CHF 20-F · filed 2021-03-31 | |
| 2019-06-30 | 998.57K CHF 6-K · filed 2019-08-15 | |
| 2018-12-31 | 1.66M CHF 20-F · filed 2020-04-16 | |
| 2017-12-31 | 9.56M CHF 20-F · filed 2019-03-14 | |
| 2016-12-31 | 12.56M CHF 20-F · filed 2018-03-22 |
USD
| Period end | Noncurrent Liabilities |
|---|---|
| 2025-06-30 | $746.88K 6-K · filed 2025-08-29 |
| 2024-12-31 | $922.77K 6-K · filed 2025-08-29 |
| 2024-06-30 | $522.99K 6-K · filed 2024-09-24 |
| 2023-12-31 | $411.92K 20-F · filed 2025-04-30 |
| 2023-01-01 | $1.88M 20-F · filed 2025-04-30 |